Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2021 Dec 14;30(1):229–239. doi: 10.1002/oby.23299

FIGURE 2.

FIGURE 2

Trends in obesogenic and nonobesogenic prescription medication use among adults, United States, 1999–2018. Percentages indicate prevalence of use among the US adult population. Prevalence estimates for obesogenic medications include adults who may also take nonobesogenic medications in the same therapeutic class. The estimates for nonobesogenic medications exclude adults who take obesogenic medications in the same therapeutic class but do not exclude adults taking an obesogenic medication in another therapeutic class